+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Corticosteroid dependent asthmatic patients are they treated sufficiently in outpatient departments? results of a retrospective analysis



Corticosteroid dependent asthmatic patients are they treated sufficiently in outpatient departments? results of a retrospective analysis



Zeitschrift fuer Erkrankungen der Atmungsorgane 177(1-2): 96-102



A retrospective descriptive analysis of 140 asthmatic patients, classified in our hospital as corticosteroid dependent and treated in outpatients departments showed, that 63% received slow release theophylline (SRT). 33% of them were within the therapeutic dose range, 44% did tolerate a further dose increase of SRT and 23% showed signs of intoxication which could be reduced by decreasing the dose. 12% of all patients were not on oral or inhaled corticosteroids at all. Only 52% received a combined antiasthmatic treatment including corticosteroids and both slow release theophylline and .beta.-agonists. This percentage was reduced to 18% if secretolytics are counted as a part of combination therapy. During hospital treatment it became evident that actually only 3% of all patients did not tolerate Theophyllin retard due to side effects. In hospital 94% of all 140 patients received combined treatment (SRT, .beta.-agonistss and corticosteroids). All of them showed a clear-cut improvement of major asthma symptoms (PEF monitoring, symptom scores, consumption of additional bronchodilators). It is concluded, that steroid dependent asthmatic out-patients are often undertreated: -a minor part does not receive steroids at all; -about one half does not receive drug therapy combined with bronchodilators; -67 per cent of the patients, who received SRT (about 2/3 of the total number) is not under optimal theophylline dose regimen.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 007165099

Download citation: RISBibTeXText


Related references

Novel approach for analysis of bronchoalveolar lavage fluid (BALF) using HPLC-QTOF-MS-based lipidomics: lipid levels in asthmatics and corticosteroid-treated asthmatic patients. Journal of Proteome Research 13(9): 3919-3929, 2015

Serum zinc levels in corticosteroid-treated asthmatic patients. Postgraduate Medical Journal 52(605): 148-150, 1976

Osteoporosis in corticosteroid-treated asthmatic patients: clinical correlates. Allergy Proceedings 14(5): 341-345, 1993

Salivary IgA and oral candidiasis in asthmatic patients treated with inhaled corticosteroid. Journal of Asthma 42(7): 601-604, 2005

Superoxide anion production by monocytes of corticosteroid-treated asthmatic patients. European Respiratory Journal 11(1): 133-138, 1998

Prednisolone-dependent asthma patients--often under-treated in ambulatory care? Results of a retrospective study. Zeitschrift für Erkrankungen der Atmungsorgane 177(1-2): 96-102, 1991

Chronic dosing effects of mediator antagonists in corticosteroid treated atopic asthmatic patients. Journal of Allergy & Clinical Immunology 113(2 Supplement): S118-S119, February, 2004

Osteoporosis in corticosteroid cs treated asthmatic patients associated clinical characteristics and the effect of vitamin d vit d therapy. Journal of Allergy & Clinical Immunology 83(1): 219, 1989

A retrospective analysis of pediatric patients with lichen sclerosus treated with a standard protocol of class I topical corticosteroid and topical calcineurin inhibitor. Journal of Dermatological Treatment 27(1): 64-66, 2016

Regulation Of The Supply Of Patients Treated At Tuberculosis Hospital Outpatient Departments With Antitubercular Agents. Tuberkulozis Es Tudobetegsegek 16: 318-319, 1963

Bone mineral density in asthmatic patients treated with inhaled corticosteroid A 4-year longitudinal study. European Respiratory Journal 12(Supplement 29): 82s, December, 1998

Repeated dosing effects of mediator antagonists in inhaled corticosteroid-treated atopic asthmatic patients. Chest 125(4): 1372-1377, 2004

Insulin shock treated at casualty departments. A retrospective analysis of 120 episodes. Ugeskrift for Laeger 148(7): 384-386, 1986

Pyogenic infections of the jaws and adjacent soft parts - retrospective analysis of 9,069 patients treated on an outpatient basis between 1969 and 1978 at the Clinic of Stomatology, University of Halle/Saale. Zahn-, Mund-, und Kieferheilkunde Mit Zentralblatt 68(4): 345-357, 1980

Inhaled corticosteroid treatment and growth of asthmatic children seen at outpatient clinics. Jornal de Pediatria 82(3): 197-203, 2006